摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-二乙基氨基二乙基胺 | 20526-69-6

中文名称
7-二乙基氨基二乙基胺
中文别名
N,N-二乙基-1,7-庚二胺;7-二乙基氨基庚胺
英文名称
α-(N,N-Diaethylamino)-w-aminoheptan
英文别名
N,N-diethyl-1,7-heptanediamine;7-diethylaminoheptylamine;N',N'-diethylheptane-1,7-diamine
7-二乙基氨基二乙基胺化学式
CAS
20526-69-6
化学式
C11H26N2
mdl
——
分子量
186.341
InChiKey
OMJKSFGVIXXFFY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    109-110.5℃
  • 沸点:
    98°C/ 6mm
  • 密度:
    0.843±0.06 g/cm3 (20 ºC 760 Torr)
  • 闪点:
    106.1±14.2℃

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    13
  • 可旋转键数:
    9
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    29.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    CORROSIVE
  • 危险品标志:
    C
  • 海关编码:
    2921290000

SDS

SDS:f15b93adb48684c6afa1d43e32e23d3f
查看

反应信息

  • 作为反应物:
    描述:
    7-二乙基氨基二乙基胺7-chloro-3,4-dihydro-3-<4-(trifluoromethyl)phenyl>-1,9(2H,10H)-acridinedione乙醇 为溶剂, 反应 1.5h, 以77%的产率得到7-Chloro-1-[(E)-7-diethylamino-heptylimino]-3-(4-trifluoromethyl-phenyl)-1,3,4,10-tetrahydro-2H-acridin-9-one
    参考文献:
    名称:
    Antimalarial drugs. 64. Synthesis and antimalarial properties of 1-imino derivatives of 7-chloro-3-substituted-3,4-dihydro-1,9(2H,10H)-acridinediones and related structures
    摘要:
    To improve upon the activity and properties of the 3-aryl-7-chloro-3,4-dihydro-1,9(2H,10H)-acridinediones, a variety of 1-[(alkylamino)alkylene]imino derivatives (3) were prepared and shown to be highly active antimalarial agents in both rodents and primates. Among structural modifications prepared, including N-10-alkyl and C2-substituted analogs, removal of the C-9 oxygen, and introduction of an imino side chain at C-9, the imines of the N-10-H acridinediones were the most active compounds obtained. The [3-(NN-dimethylamino)propyl]imino derivative of 7-chloro-3-(2,4-dichlorophenyl)-3,4-dihydro-1,9(2H,10H)-acridinedione (9aa) proved to be highly active in advanced studies in primates.
    DOI:
    10.1021/jm00097a001
点击查看最新优质反应信息

文献信息

  • Anthrapyrazole anticancer agents. Synthesis and structure-activity relationships against murine leukemias
    作者:H. D. Hollis Showalter、Judith L. Johnson、Jeanne M. Hoftiezer、William R. Turner、Leslie M. Werbel、Wilbur R. Leopold、Joan L. Shillis、Robert C. Jackson、Edward F. Elslager
    DOI:10.1021/jm00384a021
    日期:1987.1
    alkylamines provided the target "two-armed" anthrapyrazoles. A-ring 7,10-dihydroxy anthrapyrazoles were derived from amine condensation with intermediate 5-chloro-7,10-dihydroxyanthrapyrazoles or, alternatively, from intermediate 5-chloro-7,10-bis(benzyloxy)anthrapyrazoles followed by hydrogenolysis of the benzyl protecting groups to provide the target compounds. Potent in vitro activity was demonstrated against
    试图提供与米托蒽醌有关的蒽酮二酮的发色团修饰,以试图提供减少或没有心脏毒性的药剂,从而产生了新型的DNA结合物,蒽吡唑。它们的合成是通过从所需的1,4-或1,5-二氯-9,10-蒽二酮前体开始的两步缩合序列进行的。与单烷基肼反应得到氯蒽吡唑中间体,其随后与伯或仲烷基胺的缩合提供了目标“两臂”蒽吡唑。A环7,10-二羟基蒽唑是由胺与中间体5-氯-7,10-二羟基蒽唑的缩合反应衍生而来的,也可以是由中间体5-氯-7,10-双(苄氧基)蒽吡唑,然后氢解苄基保护基以提供目标化合物。在广泛的结构变异中,体外抗鼠L1210白血病(IC50 = 10(-7)-10(-8)M)以及体内P388白血病表现出强大的体外活性。通常,通过在N-2和C-5处的碱性侧链,侧链近端和远端氮之间的2至3个碳间隔基以及A环羟基化,可以最大限度地提高针对P388系的活性。除了具有针对P388品系的治疗活性外,更具活性的化合物
  • Method of stimulating the immune response with halogenated
    申请人:American Cyanamid Company
    公开号:US04226869A1
    公开(公告)日:1980-10-07
    A method of stimulating the immune response in warm-blooded animals which comprises the administration of a halogenated 10-(.omega.-dialkylaminopolymethyleneamino)-2-methoxypyrido [3,2-b]quinoline.
    在温血动物中刺激免疫反应的方法包括给予一种卤代的10-(ω-二烷基氨基聚甲烯氨基)-2-甲氧基吡啶[3,2-b]喹啉。
  • 1H-pyrazole-1-alkanamines antiarrhythmic compositions and use
    申请人:Sterling Drug Inc.
    公开号:US04916150A1
    公开(公告)日:1990-04-10
    N-[alkylamino)alkyl]-3,4(or 4,5)-diaryl-1H-pyrazole-1-(branched)alkanamides and pyrazole-1-alkanamines useful for treating cardiac arrhythmias in mammals, are prepared by reacting a lower-alkyl ester of pyrazole-1-acetic acid with an appropriate diamine followed by reduction or by reacting the anion of a lower-alkyl ester of a pyrazole-1-acetic acid with an alkylating agent followed by displacement of the ester by an appropriate amine.
    用于治疗哺乳动物心律失常的N-[烷基氨基)烷基]-3,4(或4,5)-二芳基-1H-吡唑-1-(支链)酰胺和吡唑-1-烷基胺,可通过将吡唑-1-乙酸较低烷基酯与适当的二胺反应后还原或通过将吡唑-1-乙酸较低烷基酯的阴离子与烷基化剂反应后,再用适当的胺取代酯而制备。
  • Catalyst for production of a polyurethane resin and method for producing a polyurethane resin
    申请人:——
    公开号:US20030088046A1
    公开(公告)日:2003-05-08
    Polyurethane resins are produced by reacting a polyol with a polyisocyanate in the presence of an amine catalyst of one of the formulae: 1
    聚氨酯树脂是通过在一种胺催化剂的存在下,将聚醇与聚异氰酸酯反应而制得的,该胺催化剂的化学式之一为:1
  • Catalyst for production of a polyurethane resin and method for producting a polyurethane resin
    申请人:Tosoh Corporation
    公开号:US20040147705A1
    公开(公告)日:2004-07-29
    A method for producing a polyurethane resin, which comprises reacting a polyol with a polyisocyanate in the presence of a catalyst selected from the group consisting of a catalyst (A) containing an amine compound of the following formula (1): 1 wherein each of R 1 and R 2 which are independent of each other, is a C 1-4 alkyl group, and A is a C 5-10 straight chain or branched chain alkylene group; a catalyst (B) containing an amine compound of the following formula (2): 2 a catalyst (C) containing an amine compound of the following formula (3): 3 a catalyst (D) containing a compound of the following formula (5): 4 wherein each of R 3 , R 4 and R 5 which are independent of one another, is a hydrogen atom or a C 1-4 alkyl group, R 6 is a hydrogen atom, a functional group of the following formula: 5 wherein R 7 is a hydrogen atom or a C 1-4 alkyl group, and p is an integer of from 1 to 3, or a 3-aminopropyl group, and an amine compound of the following formula (6): 6 wherein X is a nitrogen atom or an oxygen atom, each of R 8 and R 9 which are independent of each other, is a methyl group or a functional group of the following formula: 7 wherein R 10 is a hydrogen atom or a C 1-4 alkyl group, and q is an integer of from 1 to 3, and each of m and n is an integer of from 1 to 2, provided that when X is a nitrogen atom, R 8 and R 9 are not simultaneously methyl groups, and that when X is an oxygen atom, R 9 is a functional group of the following formula: 8 wherein R 10 is a hydrogen atom or a C 1-4 alkyl group, and q is an integer of from 1 to 3; and a catalyst (E) containing an amine compound of the following formula (7): 9 wherein each of R 11 , R 12 and R 13 which are independent of one another, is a hydrogen atom or a C 1-4 straight chain or branched chain alkyl group, and R 14 is a C 1-4 straight chain or branched chain alkylene group.
    一种制备聚氨酯树脂的方法,其包括在催化剂的存在下,将聚醇与聚异氰酸酯反应,所述催化剂从以下组中选择:催化剂(A)包含以下公式(1)的胺化合物:其中,R1和R2各自独立地是C1-4烷基,A是C5-10直链或支链烷基;催化剂(B)包含以下公式(2)的胺化合物:催化剂(C)包含以下公式(3)的胺化合物:催化剂(D)包含以下公式(5)的化合物:其中,R3、R4和R5各自独立地是氢原子或C1-4烷基,R6是氢原子,以下式子的功能基:其中,R7是氢原子或C1-4烷基,p是1到3之间的整数,或3-氨丙基基团,以及以下公式(6)的胺化合物:其中,X是氮原子或氧原子,R8和R9各自独立地是甲基或以下式子的功能基:其中,R10是氢原子或C1-4烷基,q是1到3之间的整数,m和n各自是1到2之间的整数,但当X是氮原子时,R8和R9不能同时为甲基,当X是氧原子时,R9是以下式子的功能基:其中,R10是氢原子或C1-4烷基,q是1到3之间的整数;以及催化剂(E)包含以下公式(7)的胺化合物:其中,R11、R12和R13各自独立地是氢原子或C1-4直链或支链烷基,R14是C1-4直链或支链烷基。
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰